openPR Logo
Press release

Cephalosporin Market - Buisness Overview, Strategies & Lucrative Opportunities Analysis 2023 | Global Players Lupin, Merck & Allergan

02-27-2019 05:25 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Cephalosporin Market - Buisness Overview, Strategies &

Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include the increase in the incidence of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea.

In addition, an increase in R&D activities to develop highly efficient & safe drugs and an upsurge in the use of combination therapies further boost market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains restrain the market growth.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/3510?utm_source=openpr_ss

The global cephalosporin market was valued at $3,136 million in 2016 and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8%.

Cephalosporin Market Key Findings:

• Branded cephalosporin segment is expected to register the highest CAGR of 14.4% during the analysis period.

• Injectable cephalosporin is accounted for more than two-fifths share of the global cephalosporin market in 2016.

• Fifth-generation cephalosporin is projected to grow at a CAGR of 15.6% during the forecast period.

• France and Germany collectively contributed to around one-third share of the European cephalosporin market in 2016.

Buy Now this Report on Special Price @ https://www.alliedmarketresearch.com/checkout/119119?utm_source=openpr_ss

Third-generation cephalosporin segment is expected to dominate the market throughout the analysis period, as these have a broader spectrum of activity. Fifth-generation cephalosporin is expected to register the highest CAGR of 7.6% during the forecast period.

Asia-Pacific is projected to register the highest CAGR of 16.1% during the forecast period, owing to increase in incidence of infectious diseases. In addition, rise in healthcare expenditure is anticipated to offer a lucrative opportunity for the market growth.

Cephalosporin Market Players:

• Lupin Limited
• Merck & Co.
• Allergan Plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc

Browse More Details of Report @ https://www.alliedmarketresearch.com/cephalosporin-market?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cephalosporin Market - Buisness Overview, Strategies & Lucrative Opportunities Analysis 2023 | Global Players Lupin, Merck & Allergan here

News-ID: 1619157 • Views: 582

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Cephalosporin

Cephalosporin Market Expert Reviews & Analysis Along With Study Report 2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the market growth. However, side effects associated with cephalosporin
Business Opportunities in Cephalosporin Market by 2023
Cephalosporin market was valued at $3,136 million in 2016, and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023. The third-generation cephalosporin segment held around one-third share of the total market in 2016. Get sample copy of this report:https://www.alliedmarketresearch.com/request-sample/3510 The introduction of combination drugs such as multiple antibacterials or antibacterials combined with an inhibitor drives the market growth. The use of combination drugs
Cephalosporin Market Strengths, Weaknesses; Key Players Analysis By QYResearchRe …
Qyresearchreports include new market research report “Global Cephalosporin Market Professional Survey Report 2018” to its huge collection of research reports. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Union Chempharma NCPC Qilu Antibiotics Lupin Pharmaceuticals Hospira Dhanuka Laboratories Fukang Dongying Pharmaceutical Alkem SALUBRIS LIVZON Hetero Drugs CSPC TEVA Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1548552&type=S The report on the global market for Cephalosporin has been prepared after conducting a fructuous analysis of several industries
Global Cephalosporin Market Specifications, Analysis Forecast 2017 to 2022
Worldwide Market Reports added Latest Research Report titled "Global Cephalosporin Market Professional Survey Report 2018" to its Large Report database. This report studies Cephalosporin in Global Market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share
Global Cephalosporin Drugs Market Professional Survey Report 2017 - 2022
This report studies Cephalosporin Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Browse complete report at https://www.researchtrades.com/report/global-cephalosporin-drugs-market-professional-survey-report-2017/1217044 This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Allergan Astellas Bristol-Myers Squibb GSK Merck Pfizer Sandoz Orchid Company Lupin TEVA HPGC Aurobindo LKPC Alkem CSPC Taj Pharma DHANUKA LABORATORIES CordenPharma SRS Pharmaceuticals Ankur Drugs and Pharma Request for sample
Cephalosporin Market Growing $1,99,754 million by 2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep throat, staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea. The global cephalosporin market is estimated to reach $1,99,754 million by